Uric Acid-specific Enzyme class drugs
2 results
Elitek (rasburicase)
(rasburicase)Sanofi-Aventis U.S. LLC
Usage: Elitek is indicated for managing elevated plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumors undergoing anticancer therapy that may cause tumor lysis. It is approved for a single course of treatment.
Krystexxa (pegloticase)
(pegloticase)Horizon Therapeutics USA, Inc.
Usage: KRYSTEXXA (pegloticase) is indicated for the treatment of chronic gout in adult patients who have not responded to conventional therapy, specifically those who cannot normalize serum uric acid with xanthine oxidase inhibitors or have contraindications to these medications. It is not recommended for asymptomatic hyperuricemia.